Inventor · disambiguated record
Si Chen
Also filed as: CHEN SI · CHEN SI-YI
17 granted patents·9 pending applications·205 citations·filing 1997–2024
93Inventor score
Files withAMPSOURCE BIOPHARMA SHANGHAI INC8BAYLOR COLLEGE MEDICINE3CHEN SI-YI2REISFELD RALPH A2SHANGHAI JUNSHI BIOSCIENCES CO LTD2
Top patents by PatentIndex Score
26 records- 0194US6500641B1Compositions and methods for identifying antigens which elicit an immune responseWAKE FOREST UNIVERSITY SCHOOL·Filed 2000·Granted Dec 31, 2002·129 cites·119 claims
- 0287US8324369B2Dendritic cell vaccine compositions and uses of sameCHEN SI-YI·Filed 2008·Granted Dec 4, 2012·13 cites·14 claims
- 0387US7868158B2Modulation of cytokine signaling regulators and applications for immunotherapyBAYLOR COLLEGE MEDICINE·Filed 2005·Granted Jan 11, 2011·15 cites·39 claims
- 0485US11833212B2Linker peptide for constructing fusion proteinAMPSOURCE BIOPHARMA SHANGHAI INC·Filed 2021·Granted Dec 5, 2023·1 cites·20 claims
- 0584US6716623B2Compositions and methods for identifying antigens which elicit an immune responseWAKE FOREST UNIVERSITY SCHOOL·Filed 2002·Granted Apr 6, 2004·14 cites·21 claims
- 0683US11123438B2Linker peptide for constructing fusion proteinAMPSOURCE BIOPHARMA SHANGHAI INC·Filed 2016·Granted Sep 21, 2021·6 cites·19 claims
- 0782US7273752B2Compositions and methods for identifying antigens which elicit an immune responseUNIV WAKE FOREST HEALTH SCIENCES·Filed 2003·Granted Sep 25, 2007·11 cites·25 claims
- 0878US10335420B2Nanoparticle-based tumor-targeted drug deliverySCRIPPS RESEARCH INST·Filed 2017·Granted Jul 2, 2019·2 cites·17 claims
- 0976US7749752B2Compositions and methods for identifying antigens which elicit an immune responseUNIV WAKE FOREST HEALTH SCIENCES·Filed 2007·Granted Jul 6, 2010·1 cites·24 claims
- 1074US2024108743A1Linker peptide for constructing fusion proteinAMPSOURCE BIOPHARMA SHANGHAI INC·Filed 2023·Application pending·0 cites
- 1173US7868159B2Modulation of negative immune regulators and applications for immunotherapyBAYLOR COLLEGE MEDICINE·Filed 2006·Granted Jan 11, 2011·4 cites·35 claims
- 1270US2022002431A1Bispecific antibody binding to cd20 and cd3 and uses thereofAMPSOURCE BIOPHARMA SHANGHAI INC·Filed 2019·Application pending·0 cites
- 1368US9629922B2Nanoparticle-based tumor-targeted drug deliveryREISFELD RALPH A·Filed 2011·Granted Apr 25, 2017·1 cites·1 claims
- 1467US9616137B2Nanoparticle-based tumor-targeted drug deliveryREISFELD RALPH A·Filed 2011·Granted Apr 11, 2017·1 cites·14 claims
- 1566US2025154138A1Small Molecule IL-17A ModulatorsBEIGENE LTD·Filed 2024·Application pending·0 cites
- 1666US2021371526A1Homodimeric bispecific antibody, preparation method therefor and use thereofAMPSOURCE BIOPHARMA SHANGHAI INC·Filed 2019·Application pending·0 cites
- 1755US2011281292A1Compositions and methods for identifying antigens which elicit an immune responseCHEN SI-YI·Filed 2010·Application pending·0 cites
- 1853US7186697B2Nucleic acid delivery system, methods of synthesis and use thereofDANA FARBER CANCER INST INC·Filed 1997·Granted Mar 6, 2007·7 cites·18 claims
- 1951US11472863B2Human coagulation factor IX (FIX) fusion protein, preparation method therefor, and use thereofAMPSOURCE BIOPHARMA SHANGHAI INC·Filed 2017·Granted Oct 18, 2022·0 cites·8 claims
- 2051US2025127915A1Anti-cldn-18.2 antibody-drug conjugate and use thereofSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2022·Application pending·0 cites
- 2150US11655292B2Anti-human NGF antibodies and methods using sameAMPSOURCE BIOPHARMA SHANGHAI INC·Filed 2020·Granted May 23, 2023·0 cites·8 claims
- 2250US11655295B2Anti-LAG-3 antibody and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2019·Granted May 23, 2023·0 cites·28 claims
- 2350US2003143228A1Human telomerase reverse transcriptase as a class-II restricted tumor-associated antigenBAYLOR COLLEGE MEDICINE·Filed 2002·Application pending·0 cites
- 2446US2022033476A1Fusion protein of mutated single-chain human coagulation factor viii, preparation method therefor, and use thereofAMPSOURCE BIOPHARMA SHANGHAI INC·Filed 2019·Application pending·0 cites
- 2545US11693008B2Match-paired monoclonal antibodies against MRJP4, ELISA kit and colloidal gold immunoassay test strip for detecting MRJP4INSTITUTE OF APICULTURAL RES CHINESE ACADEMY OF AGRICULTURAL SCIENCES·Filed 2020·Granted Jul 4, 2023·0 cites·11 claims
- 2641US2023073183A1Improved uricase and method for treating hyperuricemia using sameSHANGHAI JUNSHI BIOSCIENCES CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Si Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →